Financial News
Fibrogen Inc CS (NQ: FGEN )
0.4021
+0.0160
(+4.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Fibrogen Inc CS
![](/next-assets/images/schema-image-default.png)
FibroGen's Return on Invested Capital Overview
May 23, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
FibroGen Earnings Preview
May 05, 2023
Via Benzinga
![](https://www.marketbeat.com/logos/articles/small_20230320194830_why-did-sarepta-therapeutics-stock-plummet-in-marc.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/roce_image_394.jpeg?width=1200&height=800&fit=crop)
FibroGen's Return On Capital Employed Insights
March 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for FibroGen
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/31/fgen_logo_light__8d61590072cda19639f2b0b97776a4e9.png?width=1200&height=800&fit=crop)
B of A Securities Upgrades FibroGen: Here's What You Need To Know
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/short_image_289.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_499.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_130.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_1636.jpeg?width=1200&height=800&fit=crop)
Earnings Preview For FibroGen
February 24, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
January 31, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2132.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
January 26, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image-tripadvisor_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/05/image29.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5953.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/09/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/26/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/26/bz-pharma.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220819005384/en/1510725/4/Latest_KSF_SEC.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_4386.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220722005500/en/1510725/4/Latest_KSF_SEC.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/medical-tools-tech-therapeutics.png)
Via SBWire
![](https://mms.businesswire.com/media/20220527005391/en/1115286/4/2021-05-10-ksf-logo-sec-200.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/11/yesterdays_movers.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.